BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26813971)

  • 1. Premalignancy in Prostate Cancer: Rethinking What we Know.
    De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
    Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.
    Zhou M
    Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
    Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
    Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.
    Morais CL; Guedes LB; Hicks J; Baras AS; De Marzo AM; Lotan TL
    Hum Pathol; 2016 Sep; 55():117-25. PubMed ID: 27189342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
    Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
    Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
    Lotan TL; Gumuskaya B; Rahimi H; Hicks JL; Iwata T; Robinson BD; Epstein JI; De Marzo AM
    Mod Pathol; 2013 Apr; 26(4):587-603. PubMed ID: 23222491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.
    Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL
    Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursor lesions to prostatic adenocarcinoma.
    Epstein JI
    Virchows Arch; 2009 Jan; 454(1):1-16. PubMed ID: 19048290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
    Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
    Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
    Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
    Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal Spread Versus High-Grade Prostatic Intraepithelial Neoplasia: A Diagnostic Pitfall.
    Acosta AM; Sharif A; Groth JV; Kajdacsy-Balla A
    Int J Surg Pathol; 2016 Dec; 24(8):718-719. PubMed ID: 27605089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. My approach to intraductal lesions of the prostate gland.
    Pickup M; Van der Kwast TH
    J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal Carcinoma of the Prostate without High-Grade Invasive Adenocarcinoma: Report of Two Cases and Review of the Literature.
    Ortiz-Rey JA; Bellas-Pereira A; San Miguel-Fraile P; Morellón-Baquera R; Domínguez-Arístegui P; González-Carreró Fojón J
    Arch Esp Urol; 2022 Nov; 75(9):738-745. PubMed ID: 36472055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal carcinoma of the prostate gland with transmucosal spread to the seminal vesicle: a lesion distinct from high-grade prostatic intraepithelial neoplasia.
    Cohen RJ; Shannon BA; Weinstein SL
    Arch Pathol Lab Med; 2007 Jul; 131(7):1122-5. PubMed ID: 17617002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.
    Trabzonlu L; Kulac I; Zheng Q; Hicks JL; Haffner MC; Nelson WG; Sfanos KS; Ertunc O; Lotan TL; Heaphy CM; Meeker AK; Yegnasubramanian S; De Marzo AM
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 30082453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.